Detalhe da pesquisa
1.
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor.
Blood
; 143(20): 2059-2072, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437498
2.
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation.
Cancer
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809547
3.
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
Am J Hematol
; 97(3): 329-337, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981570
4.
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment.
Am J Hematol
; 97(11): 1443-1452, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054614
5.
Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia.
Curr Treat Options Oncol
; 21(4): 34, 2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318829
6.
Utility of protocol kidney biopsies for de novo donor-specific antibodies.
Am J Transplant
; 17(12): 3210-3218, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805293
7.
Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis.
Proc Natl Acad Sci U S A
; 109(4): 1251-6, 2012 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22232690
8.
Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
J Immunother Cancer
; 12(2)2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418394
9.
Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.
Cancer Res Commun
; 4(3): 671-681, 2024 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38391202
10.
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Blood Cancer J
; 14(1): 25, 2024 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38316746
11.
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions.
Cancer Cell
; 42(4): 605-622.e11, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458188
12.
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies.
Nat Commun
; 15(1): 1821, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418901
13.
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Cancer Immunol Res
; : OF1-OF18, 2023 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285177
14.
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Cancer Immunol Res
; 2023 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163233
15.
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.
Lancet Haematol
; 9(5): e350-e360, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483396
16.
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML.
Blood Cancer J
; 12(5): 77, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501304
17.
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia.
J Clin Oncol
; 40(33): 3848-3857, 2022 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704787
18.
Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes.
Front Immunol
; 12: 659625, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912187
19.
Clinical and molecular characterization of myeloid sarcoma without medullary leukemia.
Leuk Lymphoma
; 62(14): 3402-3410, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380367
20.
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
Lancet Haematol
; 8(8): e552-e561, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329576